Insurer-backed Qritive raises $7.5 million
Qritive has closed a $7.5 million funding round led by MassMutual Ventures, supported by SEEDS Capital, the investment arm of Enterprise Singapore, and Exfinity Venture Partners. Qritive will use this new capital to drive geographical expansion, expand product portfolio and support regulatory clearances.
Founded in 2017 by Dr. Aneesh Sathe and Dr. Kaveh Taghipour, Qritive has presence in Singapore, US, and India. Using artificial intelligence, Qritive solutions provide fast and accurate interpretations of pathology whole slide images scans within seconds, reducing time to treatment, increasing accuracy for cancer care.
“Qritive’s platform digitises and streamlines the pathology workflow from end-to-end, supporting clinicians with a wide range of tools – including image analysis, case management, and reporting modules. With an international network of pathologists, Qritive is uniquely positioned to accelerate the adoption of digital pathology across the globe. We look forward to supporting Qritive’s growth and the meaningful work that it is doing to improve patient outcomes.” – Ryan Collins, Managing Director at MassMutual Ventures.